Literature DB >> 22236653

Anti-cytokine auto-vaccinations as tools for the analysis of cytokine function in vivo.

Catherine Uyttenhove1, Jacques Van Snick.   

Abstract

Braking B cell tolerance to generate antibodies against autologous cytokines or chemokines offers an alternative to gene inactivation for functional analysis of these factors in vivo. It is clearly less potent than the genetic approach but offers the advantage of extreme flexibility. The basic principle is to enable a self-reactive B cell to attract T cell help by presenting foreign peptides, a process we called "deceptive" antigen presentation. We here review the different auto-vaccine procedures that are currently used and provide several examples of functional information acquired by this procedure or by mAbs derived from auto-vaccinated mice. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236653     DOI: 10.1016/j.cytogfr.2011.12.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  3 in total

1.  Anti-cytokine autoantibodies in autoimmune diseases.

Authors:  Giuseppe Cappellano; Elisabetta Orilieri; Abiy D Woldetsadik; Elena Boggio; Maria F Soluri; Cristoforo Comi; Daniele Sblattero; Annalisa Chiocchetti; Umberto Dianzani
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

2.  Effects of interleukin 17A (IL-17A) neutralization on murine hepatitis virus (MHV-A59) infection.

Authors:  José L Aparicio; Macarena Ottobre; Maite Duhalde Vega; Jean-Paul Coutelier; Jacques Van Snick; Lilia A Retegui
Journal:  Eur Cytokine Netw       Date:  2017-09-01       Impact factor: 2.737

3.  Active immunization with human interleukin-15 induces neutralizing antibodies in non-human primates.

Authors:  Yunier Rodríguez-Álvarez; Yanelys Morera-Díaz; Haydee Gerónimo-Pérez; Jorge Castro-Velazco; Rafael Martínez-Castillo; Pedro Puente-Pérez; Vladimir Besada-Pérez; Eugenio Hardy-Rando; Araceli Chico-Capote; Klaudia Martínez-Cordovez; Alicia Santos-Savio
Journal:  BMC Immunol       Date:  2016-09-26       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.